Page 89 - MemoriaOBN
P. 89




www.ciberobn.es

á
• o P, r B, c a, P a. Peripheral blood mononuclear cells: a potential 
Publicaciones liVereynésaiMarialou
source of homeostatic imbalance markers associated with obesity development.Pflu- 
científicas 
gers Arch. 2013 Apr;465(4):459-68.
ms relevantes
• P t, s J, P c, a w, B K, D h s .. Influence of breast- 
rieGoánchezicóhrensaMManneenauwet al
feeding on blood-cell transcript-based biomarkers of health in children.Pediatr Obes. 
2013 Nov 26;.

• M-n JM, P P, s M, o F, G-r e, o P .. De- 
orenoaVarreteetroVerranorteGaarcíauízliVeret al
creased RB1 mRNA, Protein, and Activity Reflect Obesity-Induced Altered Adipogenic 
Capacity in Human Adipose Tissue.Diabetes. 2013 Jan 11;.

• s J, n y, P a, r aM. Free fatty acid effects on myokine production 
ánchezozhenKoalouoDríGuez
in combination with exercise mimetics.Mol Nutr Food Res. 2013 Aug;57(8):1456-67.

• Palou M, PrieGo t, sánchez J, Palou a, Picó c. Metabolic programming of sirtuin 1 (SIRT1) 
expression by moderate energy restriction during gestation in rats may be related to 
Í
obesity susceptibility in later life.Br J Nutr. 2012 May 28;:1-8.
á



PROYECTOS EUROPEOS: ó
A destacar
• BIOCLAIMS (“BIOmarkers of Robustness of Metabolic Homeostasis for Nutrigenomics-de- 

rived Health CLAIMS Made on Food”, FP7-244995). 2010-2015. Coordinador: Prof. A. Palou óé
• I. Family (“Determinants of eating behavior in European children, adolescents and their 

parents”, FP7-266044). 2012-2017. IP: Prof. A. Palou por la UIB 
• DIABAT (“Recruitment and activation of brown adipocytes as preventive and curative ó

theraphy for type 2 diabetes”, HEALTH-F2-2011-278373). 2011-2015. IP: Prof. A. Palou 
por la UIB 
• SALUX (“A European Network to follow-up the reformulation of food. Identification and ex- 

change of good practices for SMEs and consumers”, grant agreement no 20101210100865). 
2011-2015. IP: Dra. M.L. Bonet por la UIB
ó
PROYECTOS NACIONALES: 

• EPIMILK (“Deteccin y caracterización de compuestos bioactivos en la leche. Un enfoque 
nutriepigenetico contra la obesidad”, AGL2012-33692). 2013-2015. IP: Prof. A. Palou ó
• 
“Identificacin y caracterizacin nutrigenómica de marcadores de alteraciones articu- 
lares en el sobrepeso y la obesidad y su potencial control por mucopolisacáridos” (CE- 
NIT-2008-1004 PRONAOS). 2008-2013. IP: Dra. M.L. Bonet y Prof. A. Palou 

• “Nutriepigentica del control de la adiposidad corporal: estudios en modelos animales de 
susceptibilidad diferencial a la obesidad basados en intervenciones nutricionales en etapas ó

vitales tempranas”. Financiado por la Fund. Ramn Areces. 2012-2015. IP: Dra. M.L. Bonet
é
PATENTES: 
“Composiciones y usos en la activacin de la termognesis”. a. Palou, c. Picó, e. ceresi, P. 

oliVer, M.P. Portillo, n. arias, M.t. Macarulla, J. MiranDa. No de solicitud: P201331329. Fecha 
de recepcin: 12 de Septiembre de 2013

ARTCULOS: 
• o P, . “Peripheral blood mononuclear cells: a potential source of homeostatic 
liVeret al
imbalance markers associated with obesity development”. Pflugers Arch 465: 459-68, 2013 
• K J, . “Oral leptin treatment in suckling rats ameliorates detrimental effects 13
oniecznaet al0
in hypothalamic structure and function caused by maternal caloric restriction during gesta-  2
tion”. PLoS One 8: e81906, 2013 AL
• NU
snchez J, et al. “Free fatty acid effects on myokine production in combination with exer- A
cise mimetics”. Mol Nutr Food Res 57: 1456-67, 2013 A 
• RI
Moreno-naVarrete JM, et al. “Decreased RB1 mRNA, protein, and activity reflect obesity- O
induced altered adipogenic capacity in human adipose tissue”. Diabetes 62: 1923-31, 2013 EM
• P a, . “Nutritional potential of metabolic remodelling of white adipose tissue”. Curr M
alouet al/ 
Opin Clin Nutr Metab Care 16: 650-6, 2013 N 
• B Ml, . “Pharmacolodical and nutritional agents promoting browning of white OB
onetet alR
adipose tissue”. Biochim Biophys Acta 1831: 969-85, 2013 BE
• P M, . “Metabolic programming of sirtuin 1 (SIRT1) expression by moderate ener- CI
alouet al
gy restriction during gestation in rats may be related to obesity susceptibility in later life”. 89
Br J Nutr 109: 757-764, 2013






   87   88   89   90   91